Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Types of Protein Post-Translational Modification

Post-translational modification (PTM) of proteins refers to the chemical changes that occur after a protein has been produced. It can impact the structure, electrophilicity and interactions of proteins. Credit: BiCyte/Shutterstock.com Types of post-translation

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Post-translational modification (PTM) of proteins refers to the chemical changes that occur after a protein has been produced. It can impact the structure, electrophilicity and interactions of proteins.

Types of post-translational modification

There are many typs of protein modification, which are mostly catalyzed by enzymes that recognize specific target sequences in proteins. These modifications regulate protein folding by targeting specific subcellular compartments, interacting with ligands or other proteins, or by bringing about a change in their functional state including catalytic activity or signaling. The most common PTMs are:

Based on the addition of chemical groups

  • Phosphorylation
  • Acetylation
  • Hydroxylation
  • Methylation

Based on the addition of complex groups

  • Glycosylation
  • AMPylation
  • Lipidation

Based on the addition of polypeptides

  • Ubiquitination

Based on the cleavage of proteins

  • Proteolysis

Based on the amino acid modification

  • Deamidation

Chemical groups

Phosphorylation

Reversible phosphorylation of proteins involves addition of a phosphate group on serine, threonine, or tyrosine residues and is one of the important and extensively studied PTM in both prokaryotes and eukaryotes.

Several enzymes or signaling proteins are switched ‘on’ or ‘off’ by phosphorylation or dephosphorylation. Phosphorylation is performed by enzymes called ‘kinases’, while dephosphorylation is performed by ‘phosphatases’.

Addition of a phosphate group can convert a previously uncharged pocket of protein into a negatively charged and hydrophilic protein thereby inducing conformational changes in the protein.

Phosphorylation has implications in several cellular processes, including cell cycle, growth, apoptosis and signal transduction pathways. One example is the activation of p53, a tumor suppressor protein. p53 is used in cancer therapeutics and is activated by phosphorylation of its N-terminal by several kinases.

Acetylation

Acetylation refers to addition of acetyl group in a protein. It is involved in several biological functions, including protein stability, location, synthesis; apoptosis; cancer; DNA stability. Acetylation and deacetylation of histone form a critical part of gene regulation.

Acetylation of histones reduces the positive charge on histone, reducing its interaction with the negatively charged phosphate groups of DNA, making it less tightly wound to DNA and accessible to gene transcription. Acetylation of p53, a tumor suppressor gene, is crucial for its growth suppressing properties.

Hydroxylation

This process adds a hydroxyl group (-OH) to the proteins. It is catalyzed by enzymes termed as ‘hydroxylases’ and aids in converting hydrophobic or lipophilic compounds into hydrophilic compounds.

Methylation

Methylation refers to addition of a methyl group to lysine or arginine residue of a protein. Arginine can be methylated once or twice, while lysine can be methylated once, twice, or thrice. Methylation is achieved by enzymes called methyltransferases. Methylation has been widely studied in histones wherein histone methylation can lead to gene activation or repression based on the residue that is methylated.

Complex groups

Glycosylation

Glycosylation involves addition of an oligosaccharide termed ‘glycan’ to either a nitrogen atom (N-linked glycosylation) or an oxygen atom (O-linked glycosylation). N-linked glycosylation occurs in the amide nitrogen of asparagine, while the O-linked glycosylation occurs on the oxygen atom of serine or threonine.

Carbohydrates present in the form of N-linked or O-linked oligosaccharides are present on the surface of cells and secrete proteins. They have critical roles in protein sorting, immune recognition, receptor binding, inflammation, and pathogenicity. For example, N-linked glycans on an immune cell can dictate how it migrates to specific sites. Similarly, it can also determine how a cell recognizes ‘self’ and ‘non-self’.

AMPylation

AMPylation refers to reversible addition of AMP to a protein. It involves formation of a phosphodiester bond between the hydroxyl group of the protein and the phosphate group of AMP.

Lipidation

The covalent binding of a lipid group to a protein is called lipidation. Lipidation can be further subdivided into prenylation, N-myristoylation, palmitoylation, and glycosylphosphatidylinositol (GPI)-anchor addition.

Prenylation involves the addition of isoprenoid moiety to a cysteine residue of a substrate protein. It is critical in controlling the localization and activity of several proteins that have crucial functions in biological regulation.

Myristoylation involves the addition of myristoyl group to a glycine residue by an amide bond. It has functions in membrane association and apoptosis. In palmitoylation, a palmitoyl group is added to a cysteine residue of a protein.

In GPI-anchor addition, the carboxyl-terminal signal peptide of the protein is split and replaced by a GPI anchor. Recent research in human genetics has revealed that GPI anchors are important for human health. Any defects in the assembling, attachment or remodeling of GPI anchors lead to genetic diseases known as inherited GPI deficiency.

Polypeptides

Ubiquitination

Ubiquitination involves addition of a protein found ubiquitously, termed ‘ubiquitin’, to the lysine residue of a substrate. Either a single ubiquitin molecule (monoubiquitination) or a chain of several ubiquitin molecules may be attached (polyubiquitination).

Polyubiquitinated proteins are recognized by the 26S proteasome and are subsequently targeted for proteolysis or degradation. Monoubiquitinated proteins may influence cell tracking and endocytosis.

Protein cleavage

Proteolysis

Proteolysis refers to breakdown of proteins into smaller polypeptides or amino acids. For example, removal of N-terminal methionine, a signal peptide, after translation leads to conversion of an inactive or non-functional protein to an active one.

Amino acid modification

Deamidation

Deamidation is the removal or conversion of asparagine or glutamine residue to another functional group. Asparagine is converted to aspartic acid or isoaspartic acid, while glutamine is converted to glutamic acid or pyroglutamic acid. This modification can change the protein structure, stability, and function.

Sources:

  • Posttranslational modification. Science Direct Topics.
  • Post translational modification. Delhi University
  • Posttranslational Modification of p53: Cooperative Integrators of Function. CSHL perspectives in Biology
  • Post translational modifications. Yale University.
  • Kinoshita T. Glycosylphosphatidylinositol (GPI) Anchors: Biochemistry and Cell Biology: Introduction to a Thematic Review Series. J Lipid Res. 2016 Jan;57(1):4-5.

Further Reading

  • All Protein Content
  • Protein Production: Initiation, Elongation and Termination
  • Protein Folding
  • Amino Acids and Protein Sequences
  • Protein Complex Analysis

Last Updated: Jul 19, 2023

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01What analytical chemistry techniques have been most important in your D-amino acid research?

Enantiomeric separations by HPLC is by far the most important technique. Mass spectrometry is more or less useless for qualitative analysis because enantiomerics have exactly the same mass, but it is useful as a sensitive detector for HPLC.

Source: www.news-medical.net ↗
02Can you provide an overview of your experience and background in research and drug discovery, including any specific areas of expertise or research interests?

My lab primarily focuses on neuroscience, but we approach problems from the perspective of axon biology. We're deeply interested in how neurons develop, undergo polarization and establish/maintain connectivity. This understanding helps not only in the development of the nervous system but also sheds light on age-related degeneration linked to the loss of axon connectivity. We use various cellular models, such as compartmentalised microfluidic neuronal cultures, to study how axons face different environments compared to cell bodies. Within this context, our research is focused on RNA biology, specifically the role of non-coding RNAs or microRNAs in regulating local axon protein synthesis. This knowledge is especially valuable when exploring different diseases and conditions like pain or neurodegeneration.

Source: www.news-medical.net ↗
03Why is this important?

The study by Williams was looking for variations in hemoglobin, the oxygen-binding protein found in red blood cells. There are disorders which lead to abnormalities in hemoglobin, which can cause serious illness or even death. Identifying these variants would lead to a better prognosis for people with such abnormalities, and the study found a variant by having the ability to differentiate between leucine and isoleucine. Methylmalonic acidemia (MMA) and propionic acidemia (PA) are metabolic disorders resulting from an inability to break down isoleucine, valine, methionine, and threonine (which are also amino acids), odd-chain fatty acids, as well as cholesterol. These are rare diseases which are known as “inborn errors of metabolism” (IEM). The restriction of certain foods and the use of medical foods can form part of the treatment for IEM disorders. Leucine is added to a lot of these medical foods, and is hence selected for patients with MMA and PA. As patients with MMA and PA cannot break down isoleucine and valine, foods containing these amino acids should be avoided. However, it was previously reported that avoiding such amino acids can lead to an imbalance in the amounts of branched chain amino acids in the blood. More specifically, the ratio of leucine to isoleucine/valine was found to be increased. This could have dire consequences, potentially disrupting the synthesis of neurotransmitters due to impaired amino acid transport into the brain. In this case, it would be pivotal to distinguish between leucine and isoleucine, as the balance between these two amino acids needs to be restored to avoid potential damage.

Source: www.news-medical.net ↗
04How does this new drug work?

The medication, called daraxonrasib, is the first drug that targets cancer-causing mutations in pancreas cells. The drug targets a mutation in the KRAS gene, part of the RAS genetic family. KRAS mutations are present in 92% of pancreatic cancers. KRAS genes normally act as an "on-off" switch for cell growth. Mutated KRAS genes are stuck in the "on" position and send out a signal that causes cells to divide and grow uncontrollably, allowing cancer to form. Daraxonrasib blocks the KRAS signal by fitting into a keyhole-type spot on the gene. That spot has a complex shape and is difficult to reach within the cell. The drug gets around this problem by using a "passenger protein" as a Trojan horse. When the cell allows this protein in, daraxonrasib tags along.

Source: www.news-medical.net ↗
05What are Introns?

Introns are nucleotide sequences in DNA and RNA that do not directly code for proteins, and are removed during the precursor messenger RNA (pre-mRNA) stage of maturation of mRNA by RNA splicing. Introns can range in size from 10’s of base pairs to 1000’s of base pairs, and can be found in a wide variety of genes that generate RNA in most living organisms, including viruses. Four distinct types of introns have been identified:

Source: www.news-medical.net ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →